rs1800629, TNF

N. diseases: 169
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Malignant tumor of cervix
CUI: C0007847
Disease: Malignant tumor of cervix
0.050 GeneticVariation BEFREE The rs361525, rs1800629, and rs17999645 were significantly correlated with the diagnosis of cervical cancer. 29940817 2018
Malignant tumor of cervix
CUI: C0007847
Disease: Malignant tumor of cervix
0.050 GeneticVariation BEFREE Published data linking single nucleotide polymorphisms (SNPs) in the tumor necrosis factor-alpha (TNF-?) promoter region at positions -308G>A (rs1800629) and -238G>A (rs361525) to cervical cancer risk have been inconclusive. 27039819 2016
Malignant tumor of cervix
CUI: C0007847
Disease: Malignant tumor of cervix
0.050 GeneticVariation BEFREE Using high-resolution melting curve analysis, we investigated the prevalence of the TNF-α -308 G/A transition (rs1800629) in patients with cervical cancer (n = 362) and control subjects (n = 399). 25614219 2015
Malignant tumor of cervix
CUI: C0007847
Disease: Malignant tumor of cervix
0.050 GeneticVariation BEFREE The TNFA-308G/A (rs1800629) and -238G/A (rs361525) polymorphisms are two widely investigated variants for their associations with risk of cervical cancer, but the results are conflicting. 21670964 2012
Malignant tumor of cervix
CUI: C0007847
Disease: Malignant tumor of cervix
0.050 GeneticVariation BEFREE There are no significant relationship between rs1800629 polymorphism and high risk HPV infection (OR = 0.649, 95% CI: 0.253-1.670, P = 0.371), cervical cancer (OR = 0.993, 95% CI: 0.376-2.618, P = 0.988), or cervical cancer with HPV infection (OR = 0.663, 95% CI: 0.250-1.758, P = 0.409). 23028877 2012